Amarin Corp (AMRN)

• Market cap: $234M
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Employees: 275

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

164% more call options, than puts

Call options by funds: $309K | Put options by funds: $117K

2% less funds holding

Funds holding: 171 [Q1] → 168 (-3) [Q2]

3.46% less ownership

Funds ownership: 22.39% [Q1] → 18.93% (-3.46%) [Q2]

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

35% less capital invested

Capital invested by funds: $81.9M [Q1] → $53.5M (-$28.4M) [Q2]

42% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 48